Rahmer Peter's Form 4/A amendment
AmendedRelay Therapeutics, Inc. (RLAY) · filed Jun 1, 2023
- Accession no.
- 0001209191-23-033421
- Filed
- Jun 1, 2023
- Trade date
- Apr 28, 2023
- Filing delay
- 34 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- May 1, 2023
This filing lists 1 non-derivative transaction. Open-market sales total $18.5K. It was filed 34 days after the trade.
This amendment replaces 0001209191-23-026280 (filed May 1, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rahmer PeterCIK 0001959229 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2023 | Common Stock | SSaleDisposed | −1,657 | $11.16 | −$18,492.12 | 156,586 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amendment is being filed to correct the number of shares sold to cover the reporting person's income tax withholding obligations upon the vesting of 5,504 shares of restricted stock units ("RSUs") on April 27, 2023, which was inadvertently understated in the reporting person's original Form 4. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- F2
Due to the error described above, the reporting person's original Form 4 incorrectly reported that the number of shares held by the reporting person was 157,504, including 132,564 shares underlying RSUs. As reported in this amendment, the correct number of shares held by the reporting person is 156,586, including 129,514 shares underlying RSUs.
Remarks
Title: Chief Corporate Development Officer